Denied
at Nordic Baltic Regional Division
10 denied decisions from Nordic Baltic Regional Division.
Denied Decisions
10 cases | Page 1 of 1
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited
This order addresses a procedural dispute regarding the costs associated with public access requests to court documents within UPC proceedings. The judge-rapporteur clarified that Article 69 UPCA, which governs cost allocation, is not applicable when parties are consulted by the judge-rapporteur under Rule 262.1(b) RoP. This ruling sets a clear boundary on who can seek reimbursement of legal costs in these specific procedural contexts, emphasizing that public access requests do not automatically trigger standard cost recovery mechanisms.
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited, Meril GmbH, Smis International OÜ, Sormedica, UAB, Interlux, UAB, Vab-Logistik, UAB
In this procedural order, the UPC Court of First Instance addressed a request by multiple defendants to stay infringement proceedings pending decisions from the EPO Opposition Division. Despite an accelerated opposition hearing being scheduled at the EPO, the Court ruled against rescheduling its own oral hearing. The decision emphasizes the need for the UPC to maintain its timeline while acknowledging the parallel proceedings, setting the stage for the main merits hearing.
TEXPORT Handelsgesellschaft mbH v.Sioen NV
This UPC CFI order addressed a preliminary objection raised by Sioen NV, challenging the jurisdiction of the Unified Patent Court over infringement proceedings concerning EP2186428. Sioen argued that parallel national court actions, including revocation and non-infringement claims in Belgium, required the UPC to decline jurisdiction under Brussels I Regulation rules. The Court rejected these arguments, finding no sufficient grounds to stay or dismiss the case. This decision reinforces the UPC's competence in handling infringement cases even when related validity challenges are pending nationally.
Edwards Lifesciences Corporation v.Meril Lifesciences PVT Limited; Meril GmbH; Smis International OÜ; Sormedica UAB
In this procedural order, the UPC denied a request by an applicant (a member of the public/investor) seeking access to all pleadings and evidence in ongoing infringement and counterclaim proceedings. The Court held that while transparency is important, the integrity of the private dispute must be protected until the case concludes. This decision reinforces the principle that requests for public access must be highly specific and demonstrate a direct, plausible interest related to the patent's subject matter.
Edwards Lifesciences Corporation v.Meril Lifesciences PVT Limited; Meril GmbH; Smis International OÜ; Sormedica UAB
This procedural order addressed a request by an applicant (a member of the public/investor) seeking access to confidential pleadings and evidence in several UPC cases. The Court ultimately denied this access, emphasizing that while transparency is important, the integrity of ongoing civil litigation must be protected. The ruling clarified that merely being a competitor or investor is insufficient grounds for disclosure when the core patent information is already public.
Edwards Lifesciences Corporation v.Meril Lifesciences PVT Limited; Meril GmbH; Smis International OÜ; Sormedica UAB
This procedural order addressed a request by an applicant (a medical device investor/competitor) seeking broad access to the court's pleadings and evidence in ongoing UPC infringement cases. The Court ultimately denied this request, emphasizing that the integrity of private civil litigation must be protected until proceedings conclude. The ruling reinforces the high bar for applicants seeking public disclosure of case materials, requiring a concrete and legitimate interest beyond general competitive curiosity.
Edwards Lifesciences Corporation v.Meril Lifesciences PVT Limited; Meril GmbH; Smis International OÜ; Sormedica UAB
In this procedural order, the UPC denied a request by an applicant (a member of the public/investor in medical devices) seeking broad access to all pleadings and evidence across multiple related infringement and counterclaim actions. The Court emphasized that while transparency is vital, the integrity of ongoing civil litigation must be protected from external interference. Since the core patent descriptions are already public, the court found no compelling reason for granting wide-ranging access at this stage.
Edwards Lifesciences Corporation v.Meril Lifesciences PVT Limited; Meril GmbH; Smis International OÜ; Sormedica UAB
This procedural order addressed a request by an applicant (a member of the public/investor) seeking broad access to pleadings and evidence in ongoing UPC infringement cases. The Court denied this access, emphasizing that the integrity of private civil litigation must be protected until proceedings conclude. While denying the immediate request, the Court granted leave to appeal, recognizing the importance of clarifying the legal interpretation regarding public access under RoP 262.1(b).
Edwards Lifesciences Corporation v.Meril Life Sciences Pvt Limited
In this procedural order, the UPC dismissed a request by multiple defendants for security for legal costs against the US-based claimant. The Court emphasized that while protecting defendants is important, it cannot unduly restrict a claimant's right to an effective remedy. The ruling clarified that the mere fact of being non-EU based is insufficient grounds for imposing security if the claimant demonstrates financial capacity and willingness to cover adverse costs.
EDWARDS LIFESCIENCES CORPORATION v.MERIL LIFE SCIENCES PVT LIMITED
In this procedural order, the UPC addressed a request by the Defendants to stay infringement proceedings pending the outcome of an opposition filed at the EPO. The Court rejected the application, emphasizing that the primary legal basis for such a stay requires the expectation of a rapid final decision from the EPO. Given the likelihood of appeals following the opposition, the court determined that the condition for staying the case was not met, allowing the infringement action to proceed.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.